Article
MGMT promoter hypermethylation is a frequent, early, and consistent event in astrocytoma progression, and not correlated with TP53 mutation.
Journal of neuro-oncology - 1 Feb 2011
Groenendijk Floris H, Taal Walter, Dubbink Hendrikus J, Haarloo Cathleen R, Kouwenhoven Mathilde C, van den Bent Martin J, Kros Johan M, Dinjens Winand N M
Abstract excerpt
Hypermethylation of the MGMT gene promoter and mutation of the TP53 tumor-suppressor gene are frequently present in diffuse astrocytomas. However, there is only anecdotal information about MGMT methylation status and TP53 mutations during progression of low-grade diffuse astrocytoma (AII) to anaplastic astrocytoma (AIII) and secondary glioblastoma (sGB). In this study biopsy specimens from 51 patients with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
